Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39

被引:602
|
作者
Read, TD
Brunham, RC
Shen, C
Gill, SR
Heidelberg, JF
White, O
Hickey, EK
Peterson, J
Utterback, T
Berry, K
Bass, S
Linher, K
Weidman, J
Khouri, H
Craven, B
Bowman, C
Dodson, R
Gwinn, M
Nelson, W
DeBoy, R
Kolonay, J
McClarty, G
Salzberg, SL
Eisen, J
Fraser, CM
机构
[1] Inst Genom Res, Rockville, MD 20850 USA
[2] Univ British Columbia, Ctr Dis Control, Vancouver, BC V5Z 1M9, Canada
[3] Univ Manitoba, Winnipeg, MB, Canada
关键词
D O I
10.1093/nar/28.6.1397
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The genome sequences of Chlamydia trachomatis mouse pneumonitis (MoPn) strain Nigg (1 069 412 nt) and Chlamydia pneumoniae strain AR39 (1 229 853 nt) were determined using a random shotgun strategy. The MoPn genome exhibited a general conservation of gene order and content with the previously sequenced C.trachomatis serovar D. Differences between C.trachomatis strains were focused on an similar to 50 kb 'plasticity zone' near the termination origins. In this region MoPn contained three copies of a novel gene encoding a >3000 amino acid toxin homologous to a predicted toxin from Escherichia coli O157:H7 but had apparently lost the tryptophan biosyntheis genes found in serovar D in this region. The C.pneumoniae AR39 chromosome was >99.9% identical to the previously sequenced C.pneumoniae CWL029 genome, however, comparative analysis identified an invertible DNA segment upstream of the uridine kinase gene which was in different orientations in the two genomes. AR39 also contained a novel 4524 nt circular single-stranded (ss)DNA bacteriophage, the first time a virus has been reported infecting C.pneumoniae. Although the chlamydial genomes were highly conserved, there were intriguing differences in key nucleotide salvage pathways: C.pneumoniae has a uridine kinase gene for dUTP production, MoPn has a uracil phosphororibosyl transferase, while C.trachomatis serovar D contains neither gene. Chromosomal comparison revealed that there had been multiple large inversion events since the species divergence of C.trachomatis and C.pneumoniae, apparently oriented around the axis of the origin of replication and the termination region. The striking synteny of the Chlamydia genomes and prevalence of tandemly duplicated genes are evidence of minimal chromosome rearrangement and foreign gene uptake, presumably owing to the ecological isolation of the obligate intracellular parasites. In the absence of genetic analysis, comparative genomics will continue to provide insight into the virulence mechanisms of these important human pathogens.
引用
收藏
页码:1397 / 1406
页数:10
相关论文
共 50 条
  • [31] In Vitro Activity of Nemonoxacin, a Novel Nonfluorinated Quinolone Antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae
    Chotikanatis, Kobkui
    Kohlhoff, Stephan A.
    Hammerschlag, Margaret R.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (03) : 1800 - 1801
  • [32] Naturally occurring amino acids differentially influence the development of Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae
    Al-Younes, Hesham M.
    Gussmann, Joscha
    Braun, Peter R.
    Brinkmann, Volker
    Meyer, Thomas F.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (07) : 879 - 886
  • [33] Chlamydia trachomatis and Chlamydophilla pneumoniae antibodies in a cohort of rheumatic patients
    Dejmkova, H
    Drazdakova, M
    Mares, Z
    Johanidesova, J
    Galatikova, D
    Vitek, P
    Petrova, S
    Lad, V
    Backovska, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 314 - +
  • [34] Influence of iron restriction on Chlamydia pneumoniae and C-trachomatis
    Freidank, HM
    Billing, H
    Wiedmann-Al-Ahmad, M
    JOURNAL OF MEDICAL MICROBIOLOGY, 2001, 50 (03) : 223 - 227
  • [35] MINING GENOME OF CHLAMYDIA TRACHOMATIS TO IDENTIFY VACCINE CANDIDATES
    Mishra, P. K.
    Jain, R.
    Chaudhry, U.
    Saluja, D.
    SEXUALLY TRANSMITTED INFECTIONS, 2015, 91 : A132 - A133
  • [36] Emergence of resistance to rifampin and rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis
    Kutlin, A
    Kohlhoff, S
    Roblin, P
    Hammerschlag, MR
    Riska, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 903 - 907
  • [37] In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae
    Malay, S
    Roblin, PM
    Reznik, T
    Kutlin, A
    Hammerschlag, MR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (02) : 517 - 518
  • [38] Genome expansion in bacteria: The curious case of Chlamydia trachomatis
    Bohlin J.
    BMC Research Notes, 8 (1)
  • [39] INVITRO EVALUATION OF ACTIVITIES OF AZITHROMYCIN, ERYTHROMYCIN, AND TETRACYCLINE AGAINST CHLAMYDIA-TRACHOMATIS AND CHLAMYDIA-PNEUMONIAE
    WELSH, LE
    GAYDOS, CA
    QUINN, TC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (02) : 291 - 294
  • [40] In vitro activity of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae
    Roblin, PM
    Reznik, T
    Kutlin, A
    Hammerschlag, MR
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 : 25 - 25